HMGA2 and gastric cancer: Another research in gastric cancer revealed that HMGA2, FOXL2, and ITGA2 were increased in metastatic lymph nodes and distant metastases in gastric cancer, and suppressing the HMGA2-FOXL2-ITGA2 pathway could serve as a new strategy in further treatment in gastric cancer [44].